From Fragmentation to Standardization: A Systematic Review Update and Critical Appraisal of Genetic and Genomic Testing Assessment Frameworks and Their Alignment With the HTA Core Model
Open Access
- 28 October 2026
- journal article
- review article
- Published by Wiley in Health Science Reports
- Vol. 9 (11)
Abstract
Background and Aims: Owing to their distinct features, genetic/genomic technologies have traditionally been assessed using tailored approaches, with no standardized methodology emerging to date. The Health Technology Assessment (HTA) Core Model (version 3.0), adopted within the European Union HTA Regulation, is a rigorous framework for health technology assessment, but its suitability for genetic/genomic testing remains unclear. This study examined whether the Model could serve as a standardized framework for the evaluation of genetic/genomic applications. Methods: A search was conducted to identify evaluation frameworks for genetic/genomic applications (PROSPERO CRD42023429403), and a critical analysis was performed. The methodological characteristics of the identified frameworks, including their assessment domains and components, were systematically compared to the domains and issues of the HTA Core Model. Findings were synthesized narratively. Results: Overall, 24 evaluation frameworks for genetic/genomic testing were analysed: half were based on the ACCE model, four on the HTA approach, one combined both methodologies, and seven were heterogeneous in structure. Only one framework covered all relevant assessment aspects but lacked validation. Conversely, the HTA Core Model captured all core questions and addressed every identified assessment component, although with varying degrees of coverage (Cohen's κ between researchers: 0.71, 95% CI: 0.59–0.82). Conclusion: Existing frameworks for genetic/genomic technologies are fragmented and mostly incomplete. As the HTA Core Model encompasses all relevant components of these technologies, it may offer a suitable basis for standardizing their evaluation process. Future research could integrate it with a few genomic‐specific items to maximize its exhaustiveness.Keywords
This publication has 60 references indexed in Scilit:
- Weighing the evidence on costs and benefits of polygenic risk-based approaches in clinical practice: A systematic review of economic evaluationsThe American Journal of Human Genetics, 2025
- European union regulation of health technology assessment: what is required for it to succeed?The European Journal of Health Economics, 2022
- The clinical utility of exome and genome sequencing across clinical indications: a systematic reviewHuman Genetics, 2021
- The PRISMA 2020 statement: An updated guideline for reporting systematic reviewsJournal of Clinical Epidemiology, 2021
- Cochrane Handbook for Systematic Reviews of Interventions2019
- Use of Decision Modelling in Economic Evaluations of Diagnostic Tests: An Appraisal and Review of Health Technology Assessments in the UKPharmacoEconomics - Open, 2018
- Implementing Genome-Driven OncologyCell, 2017
- Genetic Tests: Clinical Validity and Clinical UtilityCurrent Protocols in Human Genetics, 2014
- The challenge of implementing genetic tests with clinical utility while avoiding unsound applicationsJournal of Community Genetics, 2012
- Evaluation of genetic tests for susceptibility to common complex diseases: why, when and how?Human Genetics, 2009